The FDA did not request additional clinical or non-clinical data
Category: Uncategorized
The treatment could benefit 500 people with follicular lymphoma
Updated Date: Wed, 06 May 2020 00:00:00 EDT
Updated Date: Wed, 06 May 2020 00:00:00 EDT
Updated Date: Wed, 06 May 2020 00:00:00 EDT
Updated Date: Wed, 06 May 2020 00:00:00 EDT
Updated Date: Wed, 06 May 2020 00:00:00 EDT
Back in January, Merck said Keytruda—its anti-PD-1 therapy—had missed the mark in small cell lung cancer, an area […]
Pfizer and Astellas’ Xtandi is already approved to treat non-metastatic castration-resistant prostate cancer, thanks to data showing it […]